We are live on ! Find out more
EW

Evoke Wealth Portfolio holdings

AUM $5.57B
1-Year Est. Return 23.85%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+23.85%
3 Year Est. Return
+55.14%
5 Year Est. Return
+52.16%
10 Year Est. Return
AUM
$5.36B
AUM Growth
+$418M
Cap. Flow
+$255M
Cap. Flow %
4.75%
Top 10 Hldgs %
45.81%
Holding
743
New
92
Increased
346
Reduced
183
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 7.78%
2 Communication Services 2.61%
3 Financials 2.6%
4 Consumer Discretionary 1.87%
5 Healthcare 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
376
Eaton
ETN
$157B
$529K 0.01%
1,661
+10
+0.6% +$3.54K
GTLB icon
377
GitLab
GTLB
$5.28B
$528K 0.01%
14,076
+3,268
+30% +$141K
AMP icon
378
Ameriprise Financial
AMP
$46.8B
$525K 0.01%
1,070
+384
+56% +$182K
FOX icon
379
Fox Class B
FOX
$20.7B
$523K 0.01%
8,058
+151
+2% +$8.81K
NVS icon
380
Novartis
NVS
$295B
$522K 0.01%
3,785
+1,002
+36% +$131K
FDIS icon
381
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
$517K 0.01%
5,065
+2,688
+113% +$273K
TXN icon
382
Texas Instruments
TXN
$255B
$515K 0.01%
2,969
+334
+13% +$57.2K
ARCC icon
383
Ares Capital
ARCC
$13.5B
$515K 0.01%
25,443
+125
+0.5% +$2.52K
KALV
384
DELISTED
KalVista Pharmaceuticals
KALV
$514K 0.01%
31,841
-212
-0.7% -$2.81K
INDY icon
385
iShares S&P India Nifty 50 Index Fund
INDY
$545M
$511K 0.01%
10,365
EW icon
386
Edwards Lifesciences
EW
$47.6B
$511K 0.01%
5,991
+1,531
+34% +$126K
MO icon
387
Altria Group
MO
$122B
$507K 0.01%
8,607
+2,114
+33% +$128K
PLD icon
388
Prologis
PLD
$138B
$507K 0.01%
3,969
+1,315
+50% +$164K
IQV icon
389
IQVIA
IQV
$34.7B
$504K 0.01%
2,234
+193
+9% +$42K
MEDP icon
390
Medpace
MEDP
$16.8B
$503K 0.01%
896
+122
+16% +$69.3K
SYY icon
391
Sysco
SYY
$39.7B
$502K 0.01%
6,809
+1,266
+23% +$96.3K
PH icon
392
Parker-Hannifin
PH
$125B
$499K 0.01%
567
-57
-9% -$46.7K
GILD icon
393
Gilead Sciences
GILD
$161B
$493K 0.01%
4,020
+459
+13% +$55.8K
DXCM icon
394
DexCom
DXCM
$27.6B
$491K 0.01%
7,401
+944
+15% +$61K
CI icon
395
Cigna
CI
$76.6B
$490K 0.01%
1,781
+480
+37% +$135K
PGR icon
396
Progressive
PGR
$124B
$487K 0.01%
2,140
+564
+36% +$127K
NVO
397
Novo Nordisk
NVO
$216B
$486K 0.01%
9,556
-2,533
-21% -$130K
TGT icon
398
Target
TGT
$62.1B
$485K 0.01%
4,963
+1,482
+43% +$137K
BUSE icon
399
First Busey Corp
BUSE
$2.52B
$485K 0.01%
20,370
+283
+1% +$6.66K
NDAQ icon
400
Nasdaq
NDAQ
$51.5B
$484K 0.01%
4,978
+789
+19% +$71K

Similar funds

Evoke Wealth's Q4 2025 Portfolio in Review

As of Q4 2025, Evoke Wealth held 743 positions worth $5.36B, up 8.5% from $4.94B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Evoke Wealth deployed $255M of net new capital in Q4 2025, opening 92 new positions and adding to 346 existing holdings. Its largest new stake was GQG US Equity ETF: 112,259 shares worth $2.78M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 7.9% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21.4M trimmed.

  • Evoke Wealth's largest Q4 2025 buy was GQG US Equity ETF: 112,259 shares worth $2.78M.
  • Evoke Wealth added most to Schwab US TIPS ETF in Q4 2025, an estimated $34.4M increase.
  • Evoke Wealth's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21.4M.
  • Evoke Wealth fully exited iShares Preferred and Income Securities ETF in Q4 2025, selling an estimated $1.4M.
  • Evoke Wealth's ten largest holdings make up 46% of its $5.36B portfolio in Q4 2025.
  • Evoke Wealth opened 92 new positions and closed 59 in Q4 2025.
  • Evoke Wealth's portfolio value rose 8.5% quarter-over-quarter to $5.36B.

Based on Evoke Wealth's 13F filing for Q4 2025, filed 6 Feb 2026.